0001104659-15-009918.txt : 20150213 0001104659-15-009918.hdr.sgml : 20150213 20150213074930 ACCESSION NUMBER: 0001104659-15-009918 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150213 DATE AS OF CHANGE: 20150213 GROUP MEMBERS: HEIGHTS CAPITAL MANAGEMENT, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIND Therapeutics, Inc CENTRAL INDEX KEY: 0001385228 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87628 FILM NUMBER: 15609054 BUSINESS ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174913400 MAIL ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences, Inc DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences Inc DATE OF NAME CHANGE: 20070105 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAPITAL VENTURES INTERNATIONAL CENTRAL INDEX KEY: 0001011712 IRS NUMBER: 980158206 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: WINDWARD 1 STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1103 BUSINESS PHONE: 345-949-7576 MAIL ADDRESS: STREET 1: WINDWARD 1 STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1103 FORMER COMPANY: FORMER CONFORMED NAME: CAPITAL VENTURES INTERNATIONAL /E9/ DATE OF NAME CHANGE: 19960403 SC 13G 1 a15-4233_28sc13g.htm SC 13G

 

CUSIP No. 05548N107

13G

 

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 


 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2.

 

(Amendment No.     )*

 

BIND Therapeutics, Inc.

(Name of Issuer)

Common Stock, $.0001 par value per share

(Title of Class of Securities)

05548N107

(CUSIP Number)

February 5, 2015

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 


*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No. 05548N107

13G

 

 

 

(1)

Names of Reporting Persons
Capital Ventures International

 

 

(2)

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

(3)

SEC Use Only

 

 

(4)

Citizenship or Place of Organization
Cayman Islands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

(5)

Sole Voting Power
0

 

(6)

Shared Voting Power **
2,099,253

 

(7)

Sole Dispositive Power
0

 

(8)

Shared Dispositive Power **
2,099,253

 

 

(9)

Aggregate Amount Beneficially Owned by Each Reporting Person
2,099,253

 

 

(10)

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

(11)

Percent of Class Represented by Amount in Row (9)
9.9%

 

 

(12)

Type of Reporting Person (See Instructions)
CO

 


** Heights Capital Management, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over these shares.

 

2



 

CUSIP No. 05548N107

13G

 

 

 

(1)

Names of Reporting Persons
Heights Capital Management, Inc.

 

 

(2)

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

(3)

SEC Use Only

 

 

(4)

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

(5)

Sole Voting Power
0

 

(6)

Shared Voting Power **
2,099,253

 

(7)

Sole Dispositive Power
0

 

(8)

Shared Dispositive Power **
2,099,253

 

 

(9)

Aggregate Amount Beneficially Owned by Each Reporting Person
2,099,253

 

 

(10)

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

(11)

Percent of Class Represented by Amount in Row (9)
9.9%

 

 

(12)

Type of Reporting Person (See Instructions)
CO

 


** Heights Capital Management, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over these shares.

 

3



 

CUSIP No. 05548N107

13G

 

 

Item 1.

 

(a)

Name of Issuer
BIND Therapeutics, Inc. (the “Company”)

 

(b)

Address of Issuer’s Principal Executive Offices
325 Vassar Street, Cambridge, MA 02139

 

Item 2(a).

 

Name of Person Filing
This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons,” with respect to the shares of Common Stock of the Company, $.0001 par value per share (the “Shares”).

 

(i)      Capital Ventures International

 

(ii)     Heights Capital Management, Inc.

Item 2(b).

 

Address of Principal Business Office or, if none, Residence
The address of the principal business office of Capital Ventures International is:

 

The Harbour Trust Co. Ltd.

Windward 1, Regatta Office Park

West Bay Road

P.O. Box 897

Grand Cayman KY1-1103

Cayman Islands

 

The address of the principal business office of Heights Capital Management, Inc. is:

 

101 California Street, Suite 3250

San Francisco, California 94111

Item 2(c).

 

Citizenship
Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

Item 2(d)

 

Title of Class of Securities
Common Stock, $.0001 par value per share

Item 2(e)

 

CUSIP Number
05548N107

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

(b)

o

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(c)

o

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d)

o

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

(e)

o

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f)

o

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g)

o

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

(h)

o

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j)

o

A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

 

(k)

o

Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with

§ 240.13d-1(b)(1)(ii)(J), please specify the type of institution:____________________________

 

4



 

CUSIP No. 05548N107

13G

 

 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

The information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

 

The Shares reported as beneficially owned herein includes (i)1,391,300 Shares and, (ii)707,953 Shares issuable upon the exercise of a warrant to purchase Shares (the “Warrant”).  The Warrant is not exercisable to the extent that the total number of Shares then beneficially owned by a Reporting Person and its affiliates and any other persons whose beneficial ownership of Shares would be aggregated with such Reporting Person for purposes of Section 13(d) of the Exchange Act, as determined by the provisions of the Warrant, would exceed 9.999%.

 

The Company’s Prospectus Supplement dated February 5, 2015 (filed in connection with Registration Statement No. 333-199105), indicates there were 20,286,679 Shares outstanding as of the completion of the offering of the Shares referred to therein.

 

Heights Capital Management, Inc., which serves as the investment manager to Capital Ventures International, may be deemed to be the beneficial owner of all Shares owned by Capital Ventures International. Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:   o

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group

Not applicable.

 

Item 9.

Notice of Dissolution of Group

Not applicable.

 

5



 

CUSIP No. 05548N107

13G

 

 

Item 10.

Certification

By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURES

 

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

 

Dated: February 13, 2015

 

CAPITAL VENTURES INTERNATIONAL

 

HEIGHTS CAPITAL MANAGEMENT, INC.

 

 

 

By: Heights Capital Management, Inc. pursuant to a Limited Power of Attorney, a copy of which is filed as Exhibit I hereto.

 

By:

/s/ Brian Sopinsky

 

Name: Brian Sopinsky

 

 

Title: Secretary

By:

/s/ Brian Sopinsky

 

 

Name: Brian Sopinsky

 

 

Title: Secretary

 

 

 

6



 

CUSIP No. 05548N107

13G

 

 

EXHIBIT INDEX

 

EXHIBIT

 

DESCRIPTION

I

 

Limited Power of Attorney

II

 

Joint Filing Agreement

 

7



 

CUSIP No. 05548N107

13G

 

 

Exhibit I

 

LIMITED POWER OF ATTORNEY

 

THIS LIMITED POWER OF ATTORNEY given on the 3rd day of April, 1999 by Capital Ventures International (hereinafter called “the Company”), whose Registered Office is situated at Second Floor, One Capital Place, P.O. Box 1781, Grand Cayman Islands, B.W.I.

 

WHEREAS, by agreement dated March 10, 1997, by and between the Company and Heights Capital Management, the Company expressly authorized Heights Capital Management to enter into transactions in certain designated areas as defined in the Agreement attached hereto marked “Appendix 1.”

 

NOW THIS DEED WITNESSETH that Ian A.N. Wight (Director) and Woodburne Associates (Cayman) Limited (Secretary) of the Company, hereby appoint on behalf of the Company the firm of HEIGHTS CAPITAL MANAGEMENT which through  its officers, directors and employees is hereby formally granted limited power of attorney for the purpose of entering into transactions on behalf of and for the account of the Company and to take any actions on behalf of the Company as may be necessary to consummate such transactions, including but not limited to instructing the transfer of funds where necessary and executing required documentation.

 

IN WITNESS WHEREOF, the Company has caused its common seal to be hereunto affixed the day and year above written.

 

 

THE COMMON SEAL OF

 

CAPITAL VENTURES INTERNATIONAL

/s/ Ian A.N. Wight

was hereunto affixed in the presence of:

Ian A.N. Wight

 

(Director)

 

 

 

 

 

/s/ Woodburne Associates

 

Woodburne Associates

 

(Cayman) Limited

 

Secretary

 

8



 

EXHIBIT II

 

JOINT FILING AGREEMENT

 

This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the shares of Common Stock of BIND Therapeutics, Inc., $.0001 par value per share is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

Dated as of February 13, 2015

 

 

CAPITAL VENTURES INTERNATIONAL

 

HEIGHTS CAPITAL MANAGEMENT, INC.

 

 

 

By: Heights Capital Management, Inc. pursuant to a Limited Power of Attorney

 

By:

/s/ Brian Sopinsky

 

Name: Brian Sopinsky

 

 

Title: Secretary

By:

/s/ Brian Sopinsky

 

 

Name: Brian Sopinsky

 

 

Title: Secretary

 

 

 

9